Farhat Afrin

JIS Institute of Advanced Studies and Research, JIS University, Kolkata, India

Dr. Farhat Afrin received Ph.D. from Jadavpur University, Kolkata, India. She did postdoctoral research at National Institutes of Health, USA and, at University of York, U.K. She served Department of Biotechnology, Jamia Hamdard (University), New Delhi, India for sixteen years as an Assistant Professor and then in the Faculty of Applied Medical Sciences, Taibah University, Saudi Arabia for five years. Presently, she is an Associate Professor at Centre for Interdisciplinary Sciences, JIS Institute of Advanced Studies and Research, JIS University, Kolkata, India. Dr. Afrin is a recipient of several honors including American Association of Immunologists Young Faculty Travel Grant, Commonwealth Academic Staff fellowship, Department of Biotechnology Overseas Associateship, Indian Council of Medical Research International fellowship for Young Indian Biomedical Scientists, Department of Science and Technology Fast Track Proposal for Young Scientists. She has also been awarded a plethora of research grant-in-aids as Principal Investigator from Department of Biotechnology, Department of Science and Technology and Central Council for Research in Unani Medicine. Recently, she has received a research grant from SERB as Co-Investigator. Her research interest is immunotherapeutics, herbal and nano-medicine for leishmaniasis and other infectious diseases and cancer. She has active collaborations with distinguished scientists in India and abroad and has guided 15 students for Ph.D. She has 61 publications to her credit in Journals of International repute with a cumulative impact factor 229, H index 33 and citation record 2410 as per Scopus database. She is an Associate Editor, Editorial Board member and reviewer of several Journals and Editor of quite a few books.

Farhat Afrin

2books edited

1chapters authored

Latest work with IntechOpen by Farhat Afrin

Leishmania parasites plague the mammalian host causing high morbidity and mortality. The parasites persist in the hostile milieu, crippling its defensive arsenal. In the face of mounting resistance to an antiquated drug arsenal, new approaches are urgently desired to keep the infection at bay. Furthermore, to strengthen the leishmaniasis elimination drive, particular emphasis has to be laid on identification of new targets and vaccination strategies. This book gives a brief glimpse of the epidemiology of leishmaniasis, immune evasion, vaccination, and therapeutic modalities that may work by untangling the immunological cross-wires of pathogenic cross-talk. The Conventional treatment and its drawbacks, the prospects of phytotherapy and nanomedicines, are also discussed. The identification of drug targets with the aim of designing inhibitors is also exemplified.

Go to the book